Product Images Hydroxyzine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Hydroxyzine Hydrochloride NDC 16571-114 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 01

structural formula - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 01

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 02

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 02

This text appears to be a description of a medication. The medication is identified as "P=Rising NDC16571-113-01" and each tablet contains 10 mg of hydroxyzine hydrochloride. It is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. The recommended dosage information and full prescribing information can be found in the package insert. The medication is distributed by Hydrochloride Store and must be stored at a temperature of 20°-25°C (68°-77°F). It is dispensed in a tight container as defined in the USP, with a child-resistant closure. The text also emphasizes the importance of keeping the medication out of reach of children. The pack contains 100 tablets and has a size of approximately 15 mm.*

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 03

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 03

This is a description of a medication called hydroxyzine hydrochloride, which comes in tablet form. Each tablet contains 25 mg of the active ingredient. The usual dosage and other important information can be found in the package insert. The medication should be stored at a temperature of 20°-25°C (68°-77°F). It should be kept in a tight container with a child-resistant closure. It is important to keep this medication out of reach of children. The package contains 100 tablets and was issued in July 2023. The medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings, Inc. The provided manufacturing license number is 12/SRD/TS/2017/F/G 03011000439.*

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 04

image - 9ca46d47 3a27 47d8 b2ca a2f5719a8042 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.